ArticleInternational journal of general medicine2026
The "Dilution Effect" of Augmented Renal Clearance on the Prognostic Utility of NT-proBNP in Patients with Severe Traumatic Brain Injury.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Augmented renal clearance (ARC) constitutes a prevalent phenomenon in patients with severe traumatic brain injury (sTBI). Although N-terminal pro-B-type natriuretic peptide (NT-proBNP) serves as a valuable prognostic biomarker, its renal clearance may be accelerated in the presence of ARC, theoretically compromising its predictive accuracy. The present study aimed to quantify this "dilution effect" and construct an ARC-adjusted nomogram to optimize mortality prediction. Methods: This retrospective cohort study enrolled 352 patients with sTBI admitted to the Geriatrics ICU between June 2020 and June 2024. ARC defined as creatinine clearance >130 mL/min/1.73 m Results: Within the original cohort, 141 patients (40.1%) exhibited ARC. In the matched cohort (n=186), patients with ARC demonstrated significantly lower serum NT-proBNP levels compared to the Non-ARC group (P=0.0089), suggesting a distinct biomarker dilution effect. Multivariate analysis identified ARC status as an independent protective factor for mortality, whereas elevated NT-proBNP persisted as a risk factor. Consequently, the predictive accuracy of NT-proBNP was markedly attenuated in the ARC group (AUC=0.637) relative to the Non-ARC group (AUC=0.833). A novel nomogram integrating ARC status, Age, log-NT-proBNP, APACHE II, and Hypertension was developed. This ARC-adjusted model exhibited improved risk stratification capabilities (continuous NRI=0.590) and yielded a higher net clinical benefit than the baseline model. Conclusion: ARC is associated with significantly depressed serum NT-proBNP levels in sTBI patients, suggesting a "dilution effect" driven by enhanced renal elimination. Clinicians should interpret NT-proBNP levels with caution in this population, as reliance on standard cutoff values may lead to an underestimation of mortality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.